Untargeted metabolomics reveals that declined PE and PC in obesity may be associated with prostate hyperplasia
Open Access
- 19 April 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (4) , e0301011
Abstract
Background: Recent studies have shown that obesity may contribute to the pathogenesis of benign prostatic hyperplasia (BPH). However, the mechanism of this pathogenesis is not fully understood. Methods: A prospective case–control study was conducted with 30 obese and 30 nonobese patients with BPH. Prostate tissues were collected and analyzed using ultra performance liquid chromatography ion mobility coupled with quadrupole time-of-flight mass spectrometry (UPLC-IMS-Q-TOF). Results: A total of 17 differential metabolites (3 upregulated and 14 downregulated) were identified between the obese and nonobese patients with BPH. Topological pathway analysis indicated that glycerophospholipid (GP) metabolism was the most important metabolic pathway involved in BPH pathogenesis. Seven metabolites were enriched in the GP metabolic pathway. lysoPC (P16:0/0:0), PE (20:0/20:0), PE (24:1(15Z)/18:0), PC (24:1(15Z)/14:0), PC (15:0/24:0), PE (24:0/18:0), and PC (16:0/18:3(9Z,12Z,15Z)) were all significantly downregulated in the obesity group, and the area under the curve (AUC) of LysoPC (P-16:0/0/0:0) was 0.9922. The inclusion of the seven differential metabolites in a joint prediction model had an AUC of 0.9956. Thus, both LysoPC (P-16:0/0/0:0) alone and the joint prediction model demonstrated good predictive ability for obesity-induced BPH mechanisms. Conclusions: In conclusion, obese patients with BPH had a unique metabolic profile, and alterations in PE and PC in these patients be associated with the development and progression of BPH.Keywords
Funding Information
- the Natural Science Foundation of Hebei Province (No. H2019209595)
This publication has 59 references indexed in Scilit:
- Are Phosphatidylcholine and Lysophosphatidylcholine Body Levels Potentially Reliable Biomarkers in Obesity? A Review of Human StudiesMolecular Nutrition & Food Research, 2023
- DREAMTIME NMR Spectroscopy: Targeted Multi‐Compound Selection with Improved Detection LimitsAngewandte Chemie International Edition, 2022
- Technologies to improve the sensitivity of existing chromatographic methods used for bioanalytical studiesBiomedical Chromatography, 2020
- Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentationsAtherosclerosis, 2017
- Hepatocyte autotaxin expression promotes liver fibrosis and cancerHepatology, 2017
- Decreased phosphatidylcholine plasmalogens – A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarctionAtherosclerosis, 2016
- Phosphatidylethanolamine Metabolism in Health and Disease2016
- Rapid and sensitive LC–MS–MS determination of 2-mercaptobenzothiazole, a rubber additive, in human urineAnalytical and Bioanalytical Chemistry, 2015
- Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk FactorsCurrent Bladder Dysfunction Reports, 2010
- Effect of long‐term oral testosterone undecanoate treatment on prostate volume and serum prostate‐specific antigen concentration in eugonadal middle‐aged menThe Prostate, 1993